Results 81 to 90 of about 15,477,753 (198)

Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study.

PLoS ONE, 2015
The aim of the study was to investigate trajectories of social functioning in young people with first-episode psychosis (FEP) with and without cannabis misuse using a secondary analysis of data from the Episode-II trial.
César González-Blanch, John F Gleeson, Peter Koval, Sue M Cotton, Patrick D McGorry, Mario Alvarez-Jimenez   +5 more
doaj   +1 more source

Cannabis use, harms and the management of cannabis use disorder

Neuropsychiatry, 2014
Cannabis is the most widely used illicit drug in the world, with the highest rates of use seen in New Zealand, North America and Australia. There is evidence of a decrease in the age of commencement of cannabis use in some developed countries, and a prolongation of risk of initiation to cannabis use beyond adolescence in more recent cohorts of users ...
Jan Copeland, Nicole Clement, Wendy Swift   +2 more
openaire   +1 more source

Predicting cannabis abuse screening test (CAST) scores: a recursive partitioning analysis using survey data from Czech Republic, Italy, the Netherlands and Sweden.

PLoS ONE, 2014
IntroductionCannabis is Europe's most commonly used illicit drug. Some users do not develop dependence or other problems, whereas others do. Many factors are associated with the occurrence of cannabis-related disorders.
Matthijs Blankers, Tom Frijns, Vendula Belackova, Carla Rossi, Bengt Svensson, Franz Trautmann, Margriet van Laar   +6 more
doaj   +1 more source

Understanding Cannabis Use in Schizophrenia [PDF]

, 2011
Large-scale international surveys have found consistently high rates of cannabis use in schizophrenia and other psychotic populations (Merikangas et al., 1998; Degenhardt et al., 2001; Farrell et al., 2001).
Kavanagh, David, Kavanagh, David J., Mueser, Kim, Hides, Leanne, Mueser, Kim T.   +4 more
core   +1 more source

Risk factors for cannabis use

, 2008
This chapter explores the risk factors associated with cannabis use. In doing so, a distinction is drawn between cannabis use per se and the development of problematic cannabis use.
Coggans, Niall
core   +2 more sources

Cannabis bill: recreational use feared.

, 2017
A bill to legalise cannabis for medicinal use was rejected by the Oireachtas Health Committee out of fear that it could decriminalise the recreational use of the drug, it has emerged......
Ring, Evelyn
core  

The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder

Pain and Therapy
This narrative review explores current insights into the potential use of medicinal cannabis-related products as an emerging therapy for opioid use disorder in the landscape of increasing knowledge about medicinal cannabis-based products ...
Kelvin Le, Khang Duy Ricky Le, Johnny Nguyen, Jean Hua, Sarah Munday   +4 more
doaj   +1 more source

The risk of psychosis associated with cannabis use by people with attention-deficit hyperactivity disorder: A systematic review

Background Given that both attention-deficit hyperactivity disorder (ADHD) and cannabis use are known independent risk factors for psychosis, people with ADHD who consume cannabis may be especially vulnerable.
Suetani, Shuichi, Kesby, James P, Muller, Peter, Parker, Stephen, Honarparvar, Faraz   +4 more
core   +1 more source

The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.

BACKGROUND We examined whether cannabis use contributes to the increased risk of psychotic disorder for non-western minorities in Europe. METHODS We used data from the EU-GEI study (collected at sites in Spain, Italy, France, the United Kingdom, and ...
Murray, R M, Termorshuizen, F, Selten, J P, Szöke, A, Rutten, B P, Lasalvia, A, Llorca, P M, de Haan, L, Quattrone, D, Sanjuan, J, Santos, J L, Arango, C, Berardi, D, Tosato, S, van Os, J, la Cascia, C, Gayer-Anderson, C, Jones, P B, Kirkbride, J B, Di Forti, M, Arrojo, M, Morgan, C M, Jongsma, H E, Velthorst, E, Tarricone, I, Bernardo, M, van der Ven, E M A   +26 more
core   +1 more source

Varenicline for cannabis use disorder: a randomized controlled trial.

BACKGROUND AND AIMS: Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development.
Gray, Kevin M, Wagner, Amanda, Burt, Jessica, McRae-Clark, Aimee L, Sherman, Brian J, Chapman, Elizabeth, Baker, Nathaniel L, Steplight, Alonzo, Tolliver, Bryan   +8 more
core   +1 more source